A high-affinity Optide (optimized peptide) inhibitor of the Hippo pathway's YAP-TEAD interaction

被引：0
|
作者：
Crook, Zachary R.
Bradley, Philip
Sevilla, Gregory
Friend, Della
King, Chris
Mhyre, Andrew
Strong, Roland
Baker, David
Olson, James M.
机构：
来源：
CANCER RESEARCH | 2017年 / 77卷
关键词：
D O I：
10.1158/1538-7445.AM2017-5573
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5573
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides
    Zhou, Zheng
    Hu, Taishan
    Xu, Zhiheng
    Lin, Zhaohu
    Zhang, Zhisen
    Feng, Teng
    Zhu, Liangcheng
    Rong, Yiping
    Shen, Hong
    Luk, John M.
    Zhang, Xiongwen
    Qin, Ning
    FASEB JOURNAL, 2015, 29 (02): : 724 - 732
  • [2] Targeting the Hippo-YAP pathway with novel small-molecule inhibitors of the YAP-TEAD transcription activity
    Tang, Tracy T.
    Konradi, Andrei W.
    Feng, Ying
    Peng, Xiao
    Qiao, Sofie
    Post, Leonard
    CANCER RESEARCH, 2019, 79 (13)
  • [3] Targeting Hippo pathway by specific interruption of YAP-TEAD interaction using cyclic YAP-like peptides (vol 29, pg 724, 2015)
    Zhou, Zheng
    Hu, Taishan
    Xu, Zhiheng
    Lin, Zhaohu
    Zhang, Zhisen
    Feng, Teng
    Zhu, Liangcheng
    Rong, Yiping
    Shen, Hong
    Luk, Johnm.
    Zhang, Xiongwen
    Qin, Ning
    FASEB JOURNAL, 2017, 31 (04): : 1767 - 1767
  • [4] Identification of Celastrol as a Novel YAP-TEAD Inhibitor for Cancer Therapy by High Throughput Screening with Ultrasensitive YAP/TAZ-TEAD Biosensors
    Nouri, Kazem
    Azad, Taha
    Ling, Min
    van Rensburg, Helena J. Janse
    Pipchuk, Alexander
    Shen, He
    Hao, Yawei
    Zhang, Jianmin
    Yang, Xiaolong
    CANCERS, 2019, 11 (10)
  • [5] A covalent inhibitor of the YAP-TEAD transcriptional complex identified by high-throughput screening
    Nutsch, Kayla
    Song, Lirui
    Chen, Emily
    Hull, Mitchell
    Chatterjee, Arnab K.
    Chen, Jian Jeffery
    Bollong, Michael J.
    RSC CHEMICAL BIOLOGY, 2023, : 894 - 905
  • [6] Identification of a derivative of the alkaloid emetine as an inhibitor of the YAP-TEAD interaction and its potential as an anticancer agent
    Sekine, Saaya
    Takase, Shohei
    Hayase, Runa
    Noritsugu, Kota
    Maemoto, Yuki
    Ichikawa, Yasue
    Ogawa, Kenji
    Kondoh, Yasumitsu
    Osada, Hiroyuki
    Yoshida, Minoru
    Ito, Akihiro
    BIOSCIENCE BIOTECHNOLOGY AND BIOCHEMISTRY, 2023, 87 (05) : 501 - 510
  • [7] Antiproliferative and Antimigratory Effects of a Novel YAP-TEAD Interaction Inhibitor Identified Using in Silico Molecular Docking
    Smith, Sarah A.
    Sessions, Richard B.
    Shoemark, Deborah K.
    Williams, Christopher
    Ebrahimighaei, Reza
    McNeill, Madeleine C.
    Crump, Matthew P.
    McKay, Tristan R.
    Harris, Gemma
    Newby, Andrew C.
    Bond, Mark
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (03) : 1291 - 1305
  • [8] The Hippo pathway target, YAP, promotes metastasis through its TEAD-interaction domain
    Lamar, John M.
    Stern, Patrick
    Liu, Hui
    Schindler, Jeffrey W.
    Jiang, Zhi-Gang
    Hynes, Richard O.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (37) : E2441 - E2450
  • [9] Peptide 17, an inhibitor of YAP/TEAD4 pathway, mitigates lung cancer malignancy
    Zhang, Jirong
    Pan, Yong
    Liao, Dehua
    Tang, Jingyi
    Yao, Dunwu
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2018, 17 (07) : 1255 - 1262
  • [10] The Hippo Pathway and YAP/TAZ-TEAD Protein-Protein Interaction as Targets for Regenerative Medicine and Cancer Treatment
    Santucci, Matteo
    Vignudelli, Tatiana
    Ferrari, Stefania
    Mor, Marco
    Scalvini, Laura
    Bolognesi, Maria Laura
    Uliassi, Elisa
    Costi, Maria Paola
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (12) : 4857 - 4873
12345